Our data, that the silencing of hMENA/hMENAΔv6 in CAFs reduced GAS6 expression and secretion leading to the inhibition of CAF‐induced cancer cell invasiveness (Fig 5B, C, F, G, H), are in agreement with a recent study showing that CAF‐derived GAS6 can activate AXL and promote tumor cell migration (Kanzaki et al, 2017). This evidence concerns the gene GAS6 and neoplasm.